Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 6090316, 14 pages
http://dx.doi.org/10.1155/2016/6090316
Research Article

MP Resulting in Autophagic Cell Death of Microglia through Zinc Changes against Spinal Cord Injury

1Department of Orthopedic Surgery, First Affiliated Hospital of Liaoning Medical University, Jinzhou 121000, China
2Department of Chemistry, College of Pharmacy, Liaoning Medical University, Jinzhou 121000, China
3Department of Neurobiology , Key Laboratory of Neurodegenerative Diseases of Liaoning Province, Liaoning Medical University, Jinzhou 121000, China
4Department of Basic Medical Sciences, Liaoning Medical University, Jinzhou 121000, China

Received 4 February 2015; Accepted 16 February 2015

Academic Editor: Xuanjun Zhang

Copyright © 2016 Dingding Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. F. Ditunno Jr. and C. S. Formal, “Chronic spinal cord injury,” New England Journal of Medicine, vol. 330, no. 8, pp. 550–556, 1994. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Courtine, R. van den Brand, and P. Musienko, “Spinal cord injury: time to move,” The Lancet, vol. 377, no. 9781, pp. 1896–1898, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. M. D. Walker, “Acute spinal-cord injury,” The New England Journal of Medicine, vol. 324, no. 26, pp. 1885–1887, 1991. View at Publisher · View at Google Scholar · View at Scopus
  4. T. B. Ducker, “Treatment of spinal-cord injury,” The New England Journal of Medicine, vol. 322, no. 20, pp. 1459–1461, 1990. View at Publisher · View at Google Scholar · View at Scopus
  5. N. A. Silva, N. Sousa, R. L. Reis, and A. J. Salgado, “From basics to clinical: a comprehensive review on spinal cord injury,” Progress in Neurobiology, vol. 114, pp. 25–57, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. E. D. Hall, “Antioxidant therapies for acute spinal cord injury,” Neurotherapeutics, vol. 8, no. 2, pp. 152–167, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. M. B. Bracken, “Treatment of acute spinal cord injury with methylprednisolone: results of a multicenter, randomized clinical trial,” Journal of Neurotrauma, vol. 8, no. 1, pp. S-47–S-52, 1991. View at Google Scholar · View at Scopus
  8. J. Xu, Z. X. Qu, E. L. Hogan, and P. L. Perot Jr., “Protective effect of methylprednisolone on vascular injury in rat spinal cord injury,” Journal of Neurotrauma, vol. 9, no. 3, pp. 245–253, 1992. View at Publisher · View at Google Scholar · View at Scopus
  9. J. E. Pereira, L. M. Costa, A. M. Cabrita et al., “Methylprednisolone fails to improve functional and histological outcome following spinal cord injury in rats,” Experimental Neurology, vol. 220, no. 1, pp. 71–81, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Gorio, L. Madaschi, B. Di Stefano et al., “Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 45, pp. 16379–16384, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Tsujimoto and S. Shimizu, “Another way to die: autophagic programmed cell death,” Cell Death and Differentiation, vol. 12, supplement 2, pp. 1528–1534, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. C.-J. Lin, T.-H. Chen, L.-Y. Yang, and C.-M. Shih, “Resveratrol protects astrocytes against traumatic brain injury through inhibiting apoptotic and autophagic cell death,” Cell Death & Disease, vol. 5, no. 3, Article ID e1147, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Erlich, E. Shohami, and R. Pinkas-Kramarski, “Neurodegeneration induces upregulation of Beclin 1,” Autophagy, vol. 2, no. 1, pp. 49–51, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. R. S. Whelan, V. Kaplinskiy, and R. N. Kitsis, “Cell death in the pathogenesis of heart disease: mechanisms and significance,” Annual Review of Physiology, vol. 72, pp. 19–44, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Gotoh, Z. Lu, M. Morita et al., “Participation of autophagy in the initiation of graft dysfunction after rat liver transplantation,” Autophagy, vol. 5, no. 3, pp. 351–360, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Levine, N. Mizushima, and H. W. Virgin, “Autophagy in immunity and inflammation,” Nature, vol. 469, no. 7330, pp. 323–335, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Deretic, T. Saitoh, and S. Akira, “Autophagy in infection, inflammation and immunity,” Nature Reviews Immunology, vol. 13, no. 10, pp. 722–737, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Saitoh, N. Fujita, M. H. Jang et al., “Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production,” Nature, vol. 456, no. 7219, pp. 264–268, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Scharl and G. Rogler, “Inflammatory bowel disease: dysfunction of autophagy?” Digestive Diseases, vol. 30, supplement 3, pp. 12–19, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. A. A. Yunice, A. W. Czerwinski, and R. D. Lindeman, “Influence of synthetic corticosteroids on plasma zinc and copper levels in humans,” The American Journal of the Medical Sciences, vol. 282, no. 2, pp. 68–74, 1981. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Scott, B. Ferrie, A. Mc Lelland, and G. S. E. Fell, “The effect of steroid therapy on serum trace metal levels in sub-fertile males,” Urological Research, vol. 12, no. 4, pp. 213–215, 1984. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Peretz, J. Neve, and J. P. Famaey, “Effects of chronic and acute corticosteroid therapy on zinc and copper status in rheumatoid arthritis patients,” Journal of Trace Elements and Electrolytes in Health and Disease, vol. 3, no. 2, pp. 103–108, 1989. View at Google Scholar · View at Scopus
  23. N. V. Rekers, I. M. Bajema, M. J. K. Mallat et al., “Increased metallothionein expression reflects steroid resistance in renal allograft recipients,” American Journal of Transplantation, vol. 13, no. 8, pp. 2106–2118, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Yamasaki, K. Sakata-Sogawa, A. Hasegawa et al., “Zinc is a novel intracellular second messenger,” Journal of Cell Biology, vol. 177, no. 4, pp. 637–645, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. D. M. Basso, M. S. Beattie, and J. C. Bresnahan, “Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection,” Experimental Neurology, vol. 139, no. 2, pp. 244–256, 1996. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. Li, G.-H. Guo, G.-S. Wang, C.-X. Guan, and L. Yue, “Influence of neural stem cell transplantation on angiogenesis in rats with spinal cord injury,” Genetics and Molecular Research, vol. 13, no. 3, pp. 6083–6092, 2014. View at Publisher · View at Google Scholar
  27. S. Tada, T. Okuno, T. Yasui et al., “Deleterious effects of lymphocytes at the early stage of neurodegeneration in an animal model of amyotrophic lateral sclerosis,” Journal of Neuroinflammation, vol. 8, no. 1, article 19, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Wang, R. Su, G. Lv et al., “Supplement zinc as an effective treatment for spinal cord ischemia/reperfusion injury in rats,” Brain Research, vol. 1545, pp. 45–53, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. M. K. Mishra, J. Wang, M. B. Keough et al., “Laquinimod reduces neuroaxonal injury through inhibiting microglial activation,” Annals of Clinical and Translational Neurology, vol. 1, no. 6, pp. 409–422, 2014. View at Publisher · View at Google Scholar
  30. A. Henn, S. Lund, M. Hedtjärn, A. Schrattenholz, P. Pörzgen, and M. Leist, “The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation,” Altex, vol. 26, no. 2, pp. 83–94, 2009. View at Google Scholar · View at Scopus
  31. S. Vasto, E. Mocchegiani, G. Candore et al., “Inflammation, genes and zinc in ageing and age-related diseases,” Biogerontology, vol. 7, no. 5-6, pp. 315–327, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Baruch, L. Gur-Arie, C. Nadler et al., “Metalloprotease type III effectors that specifically cleave JNK and NF-κB,” The EMBO Journal, vol. 30, no. 1, pp. 221–231, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. R. M. Ransohoff and A. E. Cardona, “The myeloid cells of the central nervous system parenchyma,” Nature, vol. 468, no. 7321, pp. 253–262, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Nimmerjahn, F. Kirchhoff, and F. Helmchen, “Neuroscience: resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo,” Science, vol. 308, no. 5726, pp. 1314–1318, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Saijo and C. K. Glass, “Microglial cell origin and phenotypes in health and disease,” Nature Reviews Immunology, vol. 11, no. 11, pp. 775–787, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. H. D. VanGuilder, G. V. Bixler, R. M. Brucklacher et al., “Concurrent hippocampal induction of MHC II pathway components and glial activation with advanced aging is not correlated with cognitive impairment,” Journal of Neuroinflammation, vol. 8, article 138, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. M. A. Burguillos, T. Deierborg, E. Kavanagh et al., “Caspase signalling controls microglia activation and neurotoxicity,” Nature, vol. 472, no. 7343, pp. 319–324, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. F. M. Bareyre and M. E. Schwab, “Inflammation, degeneration and regeneration in the injured spinal cord: insights from DNA microarrays,” Trends in Neurosciences, vol. 26, no. 10, pp. 555–563, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Wirawan, T. Vanden Berghe, S. Lippens, P. Agostinis, and P. Vandenabeele, “Autophagy: for better or for worse,” Cell Research, vol. 22, no. 1, pp. 43–61, 2012. View at Google Scholar
  40. S. Sasaki, “Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis,” Journal of Neuropathology & Experimental Neurology, vol. 70, no. 5, pp. 349–359, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Zhang, P. Tang, H. Hou et al., “Autophagy reduces neuronal damage and promotes locomotor recovery via inhibition of apoptosis after spinal cord injury in rats,” Molecular Neurobiology, vol. 49, no. 1, pp. 276–287, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Diskin, P. Tal-Or, S. Erlich et al., “Closed head injury induces upregulation of beclin 1 at the cortical site of injury,” Journal of Neurotrauma, vol. 22, no. 7, pp. 750–762, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Takatsuka, Y. Inoue, K. Matsuoka, and Y. Moriyasu, “3-Methyladenine inhibits autophagy in tobacco culture cells under sucrose starvation conditions,” Plant and Cell Physiology, vol. 45, no. 3, pp. 265–274, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. J. P. Liuzzi and C. Yoo, “Role of Zinc in the regulation of autophagy during ethanol exposure in human hepatoma cells,” Biological Trace Element Research, vol. 156, no. 1–3, pp. 350–356, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. S.-J. Lee, K. S. Cho, and J.-Y. Koh, “Oxidative injury triggers autophagy in astrocytes: the role of endogenous zinc,” Glia, vol. 57, no. 12, pp. 1351–1361, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Foster and S. Samman, “Zinc and Regulation of inflammatory cytokines: implications for cardiometabolic disease,” Nutrients, vol. 4, no. 7, pp. 676–694, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. C. J. Frederickson, J.-Y. Koh, and A. I. Bush, “The neurobiology of zinc in health and disease,” Nature Reviews Neuroscience, vol. 6, no. 6, pp. 449–462, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. B. Besecker, S. Bao, B. Bohacova, A. Papp, W. Sadee, and D. L. Knoell, “The human zinc transporter SLC39A8 (Zip8) is critical in zinc-mediated cytoprotection in lung epithelia,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 294, no. 6, pp. L1127–L1136, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. M.-J. Liu, S. Bao, M. Gálvez-Peralta et al., “ZIP8 regulates host defense through zinc-mediated inhibition of NF-κB,” Cell Reports, vol. 3, no. 2, pp. 386–400, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. T. G. Sommermann, H. I. D. Mack, and E. Cahir-McFarland, “Autophagy prolongs survival after NFκB inhibition in B-cell lymphomas,” Autophagy, vol. 8, no. 2, pp. 265–267, 2012. View at Publisher · View at Google Scholar · View at Scopus